SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-092586
Filing Date
2023-08-16
Accepted
2023-08-16 16:37:45
Documents
39
Period of Report
2023-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321991d1_8k.htm   iXBRL 8-K 245196
2 EXHIBIT 3.1 tm2321991d1_ex3-1.htm EX-3.1 39253
3 EXHIBIT 3.2 tm2321991d1_ex3-2.htm EX-3.2 172547
4 EXHIBIT 3.3 tm2321991d1_ex3-3.htm EX-3.3 116849
5 EXHIBIT 4.1 tm2321991d1_ex4-1.htm EX-4.1 14714
6 EXHIBIT 4.2 tm2321991d1_ex4-2.htm EX-4.2 26056
7 EXHIBIT 4.4 tm2321991d1_ex4-4.htm EX-4.4 22825
8 EXHIBIT 10.1 tm2321991d1_ex10-1.htm EX-10.1 143349
9 EXHIBIT 10.14 tm2321991d1_ex10-14.htm EX-10.14 103947
10 EXHIBIT 10.15 tm2321991d1_ex10-15.htm EX-10.15 112419
11 EXHIBIT 10.16 tm2321991d1_ex10-16.htm EX-10.16 74191
12 EXHIBIT 10.17 tm2321991d1_ex10-17.htm EX-10.17 132813
13 EXHIBIT 10.18 tm2321991d1_ex10-18.htm EX-10.18 66856
14 EXHIBIT 10.19 tm2321991d1_ex10-19.htm EX-10.19 123933
15 EXHIBIT 10.20 tm2321991d1_ex10-20.htm EX-10.20 64942
16 EXHIBIT 10.21 tm2321991d1_ex10-21.htm EX-10.21 251413
17 EXHIBIT 10.22 tm2321991d1_ex10-22.htm EX-10.22 75519
18 EXHIBIT 10.23 tm2321991d1_ex10-23.htm EX-10.23 59121
19 EXHIBIT 10.24 tm2321991d1_ex10-24.htm EX-10.24 114137
20 EXHIBIT 10.25 tm2321991d1_ex10-25.htm EX-10.25 85466
21 EXHIBIT 10.26 tm2321991d1_ex10-26.htm EX-10.26 22908
22 EXHIBIT 16.1 tm2321991d1_ex16-1.htm EX-16.1 2736
23 EXHIBIT 21.1 tm2321991d1_ex21-1.htm EX-21.1 1744
24 EXHIBIT 99.1 tm2321991d1_ex99-1.htm EX-99.1 316131
25 EXHIBIT 99.2 tm2321991d1_ex99-2.htm EX-99.2 285971
26 EXHIBIT 99.3 tm2321991d1_ex99-3.htm EX-99.3 245756
27 EXHIBIT 99.4 tm2321991d1_ex99-4.htm EX-99.4 23423
  Complete submission text file 0001104659-23-092586.txt   3745662

Data Files

Seq Description Document Type Size
28 XBRL TAXONOMY EXTENSION SCHEMA tlsi-20230810.xsd EX-101.SCH 3281
29 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlsi-20230810_def.xml EX-101.DEF 28201
30 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlsi-20230810_lab.xml EX-101.LAB 37602
31 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlsi-20230810_pre.xml EX-101.PRE 26413
33 EXTRACTED XBRL INSTANCE DOCUMENT tm2321991d1_8k_htm.xml XML 6309
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39813 | Film No.: 231178678
SIC: 8071 Services-Medical Laboratories